The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia.
The combination of venetoclax and rituximab for the treatment of patients with recurrent chronic lymphocytic leukemia. Expert Rev Hematol. 2020 08; 13(8):885-894.